Discover
VVOS
Vivos Therapeutics, Inc.
0.30
2 x 0.29
1 x 0.30
bid
ask
-
0.02
4.97%
01:34 PM
timesize
| Ytd | -85.13% | |
| 1y | -93.41% |
0.29
day range
0.36
0.29
52 week range
5.12
| Open | 0.33 | Prev Close | 0.32 | Low | 0.29 | High | 0.36 | Mkt Cap | 4.17M |
| Vol | 5.12M | Avg Vol | 2.38M | EPS | -2.14 | P/E | -0.14 | Forward P/E | -9.31 |
| Beta | 6.22 | Short Ratio | 0.66 | Inst. Own | 13.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.49 | 200-d Avg | 1.35 | 1yr Est | 6.30 |
| Income Statement | |||
| Total Revenue | 5.14M | ||
| Revenues (USD) | 5.14M | ||
| Cost of Revenue | 2.08M | ||
| Gross Profit | 3.06M | ||
| Operating Expenses | 9.67M | ||
| Selling, General and Administrative Expense | 9.22M | ||
| Operating Income | -6.61M | ||
| Net Income | -7.68M | ||
| Net Income Common Stock | -7.68M | ||
| Net Income Common Stock (USD) | -7.68M | ||
| Consolidated Income | -7.75M | ||
| Net Income to Non-Controlling Interests | -69.00K | ||
| Earnings per Basic Share | -0.52 | ||
| Earnings per Basic Share (USD) | -0.52 | ||
| Earnings per Diluted Share | -0.52 | ||
| Earning Before Interest & Taxes (EBIT) | -7.68M | ||
| Earning Before Interest & Taxes (USD) | -7.68M | ||
| Weighted Average Shares | 14.63M | ||
| Weighted Average Shares Diluted | 14.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.11M | ||
| Cash and Equivalents (USD) | 2.11M | ||
| Trade and Non-Trade Receivables | 1.77M | ||
| Current Assets | 4.82M | ||
| Property, Plant & Equipment Net | 7.56M | ||
| Total Assets | 25.04M | ||
| Debt Current | 8.10M | ||
| Total Debt | 12.27M | ||
| Current Liabilities | 17.94M | ||
| Debt Non-Current | 4.17M | ||
| Total Liabilities | 26.31M | ||
| Accumulated Retained Earnings (Deficit) | -133.04M | ||
| Shareholders Equity | -1.40M | ||
| Shareholders Equity (USD) | -1.40M | ||
| Assets Non-Current | 20.22M | ||
| Total Debt (USD) | 12.27M | ||
| Goodwill and Intangible Assets | 12.41M | ||
| Liabilities Non-Current | 8.37M | ||
| Trade and Non-Trade Payables | 2.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 454.00K | ||
| Net Cash Flow from Financing | 6.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 81.00K | ||
| Capital Expenditure | -18.00K | ||
| Issuance (Purchase) of Equity Shares | 5.55M | ||
| Issuance (Repayment) of Debt Securities | 980.00K | ||
| Net Cash Flow from Investing | -18.00K | ||
| Net Cash Flow from Operations | -6.01M | ||
| Share Based Compensation | 151.00K | ||